| Identification | More | [Name]
Fmoc-3-(2-Naphthyl)-D-alanine | [CAS]
138774-94-4 | [Synonyms]
D-FMOC-2-NAL-OH
FMOC-3-(2-NAPHTHYL)-D-ALANINE
FMOC-BETA-(2-NAPHTHYL)-D-ALANINE
FMOC-D-2-NAL-OH
FMOC-D-2-NAPHTHYLALANINE
FMOC-D-3-(2-NAPHTHYL)-ALANINE
FMOC-D-ALA(2-NAPH)-OH
FMOC-D-ALA(2-NAPHTHYL)-OH
FMOC-D-ALA-BETA-(2-NAPHTHYL)-OH
FMOC-D-NAL(2)
FMOC-D-NAL(2)-OH
N-(9-FLUORENYLMETHOXYCARBONYL)-2-NAPHTHYL-D-ALANINE
N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-3-(2-NAPHTHYL)-D-ALANINE
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-3-(2-NAPHTHYL)-D-ALANINE
N-ALPHA-(9-FLUORENYLOXYCARBONYL)-D-3-(2-NAPHTHYL)ALANINE
N-ALPHA-FMOC-BETA-(2-NAPHTHYL)-D-ALANINE
(R)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-NAPHTHALEN-2-YL-PROPIONIC ACID
RARECHEM BK PT 0102
(R)-N-FMOC-2-NAPHTHYLALANINE
FMOC-D-2-NAPHTHYLALANINE 99+% | [Molecular Formula]
C28H23NO4 | [MDL Number]
MFCD00077044 | [Molecular Weight]
437.49 | [MOL File]
138774-94-4.mol |
| Chemical Properties | Back Directory | [Appearance]
off-white to light beige crystalline powder | [Melting point ]
191 °C
| [Boiling point ]
549.64°C (rough estimate) | [density ]
1.2227 (rough estimate) | [refractive index ]
1.6290 (estimate) | [storage temp. ]
2-8°C
| [solubility ]
Chloroform (Slightly, Sonicated), DMF (Sparingly, Sonicated), DMSO (Slightly) | [form ]
Solid | [pka]
3.77±0.30(Predicted) | [color ]
White to Off-White | [Water Solubility ]
Slightly soluble in water. | [BRN ]
7864489 | [CAS DataBase Reference]
138774-94-4(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Safety Statements ]
S24/25:Avoid contact with skin and eyes .
S22:Do not breathe dust . | [WGK Germany ]
3
| [HazardClass ]
IRRITANT | [HS Code ]
29242990 |
| Hazard Information | Back Directory | [Chemical Properties]
off-white to light beige crystalline powder | [Uses]
Fmoc-3-(2-naphthyl)-D-alanine is an intermediate used in the preparation of phosphoserine-containing tetrapeptides with hydrophobic N-terminal acyl groups as inhibitors of the BRCA1 protein. | [reaction suitability]
reaction type: Fmoc solid-phase peptide synthesis |
|
|